EP1091808B1 - Device for determining an analyte in a liquid sample - Google Patents
Device for determining an analyte in a liquid sample Download PDFInfo
- Publication number
- EP1091808B1 EP1091808B1 EP99925064A EP99925064A EP1091808B1 EP 1091808 B1 EP1091808 B1 EP 1091808B1 EP 99925064 A EP99925064 A EP 99925064A EP 99925064 A EP99925064 A EP 99925064A EP 1091808 B1 EP1091808 B1 EP 1091808B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- zone
- capillary
- diffusion means
- support
- capillary diffusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0825—Test strips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0633—Valves, specific forms thereof with moving parts
- B01L2400/065—Valves, specific forms thereof with moving parts sliding valves
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/806—Fertility tests
Definitions
- the present invention relates to a device for determination of an analyte present in a sample liquid.
- Analyte means any entity, chemical, biochemical, or biological, that we want to determine, that is to say, identify or detect, and / or quantify, and / or measure.
- the present invention will be introduced, defined, and described by reference to the determination of a biological entity, especially a hormone, for example the hormone hcG to detect the pregnancy status of a woman.
- Liquid sample means any sample in which the analyte sought is in solution or suspension, as directly applied or treated by the device of determination of which it will be question below.
- This liquid sample can itself have been obtained from a sample or other sample containing the analyte, for example a fluid body, by physical treatment, and / or chemical, and / or organic. This means in particular that the middle of Dissolution or dispersion belonging to the sample liquid is not necessarily aqueous.
- the user removes the cap, then puts the liquid sample, for example a stream of urine, in direct contact with the collection area of the second means of capillary diffusion.
- the liquid sample migrates first, in the reference direction, to the zone upstream of the first capillary diffusion means, in which, on the one hand, causes the first reagent, and on the other hand the analyte binds to the latter, to form a conjugate.
- the aforementioned conjugate arrives via capillary drive in the downstream zone, in which the second reagent captures, and therefore immobilizes and concentrate, directly or indirectly, the first reagent, and hence the conjugate.
- the existence and / or the captured quantity of the conjugate can be read, and / or measured, directly or indirectly, for example to the naked eye in the case of a particulate marker, or by any means of detection and / or appropriate measure.
- the two devices previously described have in on the one hand, the provision of the two means of capillary diffusion, on one and the same element, know the grip support in the first case, and the movable organ in the second case, and on the other hand a structural continuity of capillary flow, this is at say permanent, the liquid sample of the second means of capillary diffusion to the first means of capillary diffusion.
- the present invention relates to a device for removing any additional means of removable protection of the collection area of the liquid sample, while isolating the latter from the outside of the device, as the latter is not used, ie used or armed for taking a liquid sample, and then reading the result concerning the analyte.
- a device Compared to WO 97/26083, a device according to the present invention is distinguished in that the transfer zone of the second capillary diffusion means is removably arranged with respect to an upstream zone of the first capillary diffusion means, so that, in the projecting position of the capturing member, said transfer zone is not in continuity of capillary flow with said upstream zone, and in the retracted position of said capturing member, said transfer zone and said zone upstream are in continuity of capillary flow, while a set of reagents predetermined for the detection and / or quantification of the analyte comprises at least, on the one hand a first reagent comprising a marker, visible and / or measurable, deposited in the free state, or on the first capillary diffusion means, upstream of said downstream zone, or on the second capillary diffusion means, and secondly a second reagent fixed in the zone e downstream of the first capillary diffusion means, for the direct or indirect capture of the first reagent.
- the device according to the invention is distinguished by the dissociation of the two means of capillary diffusion, and by the possibility of isolating temporarily these two means with respect to the flow capillary of the liquid sample.
- the device according to the invention is distinguished, besides the set of predetermined reagents chosen for the detection and / or quantification of the analyte, by the fact that the first means of capillary diffusion remains side of the gripping support, and as a result the capture organ is essentially assigned to the sampling of the liquid sample.
- the invention brings the following advantages.
- the displacement of the second diffusion means capillary, away from and away from the first means of capillary diffusion, allows for a length or a given size of the device, to have a more large collection length of the liquid sample, in the projecting or protruding position of said device.
- a device according to the invention can be used with any set of predetermined reagents, depending of the desired analyte in the liquid sample, of a and the operating protocol adopted for the determination on the other hand.
- Reagent means any entity, chemical, biochemical, or biological likely to bind with the analyte and / or another reagent.
- binding is meant any link strong, for example covalent, or weak, for example type antigen / antibody or avidin / streptavidin.
- the reagents considered according to the invention are entities ligand or anti-ligand type, and this by relative to the analyte or other reagent, of type organic.
- the reagents such as antibodies, antigens, haptens, avidin / streptavidin, but also peptides, proteins, and polynucleotides.
- the first and second reagents are respectively two monoclonal antibodies specific, identical or different, directed against the analyte.
- Marker means any physical entity, chemical, biochemical, or biological, allowing directly or indirectly the determination of the first reagent, particularly when bound, directly or indirectly indirectly, to the analyte.
- a marker known per se, can be for example an enzyme, or particles metal, for example gold particles, obtained by example from colloidal gold.
- the first reagent is deposited on the second means of capillary diffusion, in particular downstream of the organ collection area of capture, or the first reagent is deposited on the first means of capillary diffusion, in particular downstream of the upstream zone of the said first means, but upstream of the downstream zone accessible to an observation external.
- an analyte constituted by a biological entity comprising two ligands, likely to link with the first reagent and a third reagent the latter is deposited at the free state, on a porous support, in this case the second means of capillary diffusion or the first means capillary scattering at a functionally upstream of the downstream zone of the first diffusion means.
- the second reagent is predetermined for capturing the third reagent.
- another predetermined reagent for binding directly or indirectly with the first reagent is fixed in a adjacent area but downstream of the downstream zone of the first means of diffusion, this adjacent zone being also accessible to an external observation.
- the first reagent comprises a particulate marker, for example gold particles, visible and / or directly measurable, when concentrated in the downstream zone of the first diffusion means.
- a particulate marker for example gold particles, visible and / or directly measurable
- the support of 1 comprises a longitudinal slide 5, of which the shape is adapted to the movement path of said member 4, and the latter comprises a control member 6 manual crossing this slide.
- the race of the organ 6 in the slide 5 determines the two extreme positions of the capture member 4, and as shown in FIG. has a length greater than the recovery length of the transfer zone 41b of the second diffusion means 41 capillary, and the upstream zone (2b) of the first means of capillary diffusion, in the retracted position of device.
- the first means 2 of capillary diffusion is obtained by assembling different sections or pieces, themselves fixed on a band 28 made of plastic transparent, and in permanent continuity of flow capillary when assembled to each other.
- the capture member 4 comprises a carriage 42 of supporting the second means 41 of capillary diffusion, included in the housing 1 or gripping support.
- This last and the carriage 42 comprise guide means moving said carriage, more particularly visible in Figure 6, consisting of two slides 45 and 46 belonging to the housing 1, the superior and the other bottom, and aligned, and in two ribs 43 and 44 corresponding to the carriage 42, sliding in the slides 45 and 46 respectively.
- the second diffusion means 41 is in the form of a relatively rigid rod, and the carriage 42 comprises a rear stop 42a with respect to the direction of travel said carriage, and a member 42b for holding the rod 41, having the shape of a ring.
- the housing 1 also includes a means 47 for actuating the carriage 42, with manual control 48. More specifically, the actuating means 47 comprises a band 49 semi-rigid, shaped hairpin, one of which branch 49a has on its outer face a member 48 the other limb has one end linked to the carriage 42.
- the housing 1 comprises a path 50 for guiding and pulling the strip, also shaped hairpin, and secondly a 1f window adapted to the passage of the organ of 48, the length of which is adapted to the race of displacement of the capture organ 4. as shown the comparison between figures 4 and 5, this race a much longer length than the recovery length of the transfer zone 41b of the second means of capillary diffusion 41, and the upstream zone 2b of the first capillary diffusion means 2, in the position retracted device.
- the band 49 circulates in the guide path 50 and pushes the carriage 42 towards the protruding position of the capture member 2. In sense reverse, the carriage 42 is moved to the position retracted from the capture member 4.
- the first means 2 of capillary diffusion is tight and kept inside the housing between ribs on arranged parallel to the flow direction 60 capillary.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
La présente invention concerne un dispositif de détermination d'un analyte présent dans un échantillon liquide.The present invention relates to a device for determination of an analyte present in a sample liquid.
Par "analyte", on entend toute entité, chimique, biochimique, ou biologique, que l'on veut déterminer, c'est-à-dire identifier ou détecter, et/ou quantifier, et/ou mesurer."Analyte" means any entity, chemical, biochemical, or biological, that we want to determine, that is to say, identify or detect, and / or quantify, and / or measure.
A titre préférentiel, et de manière non exclusive, la présente invention sera introduite, définie, et décrite par référence à la détermination d'une entité biologique, notamment une hormone, par exemple l'hormone hcG permettant de détecter l'état de grossesse d'une femme.As a preferential, and non-exclusive, the present invention will be introduced, defined, and described by reference to the determination of a biological entity, especially a hormone, for example the hormone hcG to detect the pregnancy status of a woman.
Par "échantillon liquide", on entend tout échantillon dans lequel l'analyte recherché est en solution ou suspension, tel qu'il est directement appliqué ou traité par le dispositif de détermination dont il sera question ci-après. Cet échantillon liquide peut lui-même avoir été obtenu à partir d'un prélèvement ou autre échantillon contenant l'analyte, par exemple un fluide corporel, par traitement physique, et/ou chimique, et/ou biologique. Ceci signifie en particulier que le milieu de dissolution ou dispersion appartenant à l'échantillon liquide n'est pas nécessairement aqueux."Liquid sample" means any sample in which the analyte sought is in solution or suspension, as directly applied or treated by the device of determination of which it will be question below. This liquid sample can itself have been obtained from a sample or other sample containing the analyte, for example a fluid body, by physical treatment, and / or chemical, and / or organic. This means in particular that the middle of Dissolution or dispersion belonging to the sample liquid is not necessarily aqueous.
Conformément aux Figures 8 et 9 du document EP-A-0291 194, on a décrit un dispositif de détermination d'un analyte, en particulier pour la détermination de l'hormone hcG, répondant à la définition générale suivante.According to Figures 8 and 9 of EP-A-0291 194, there has been described a device for determining a analyte, especially for the determination of the hormone hcG, as defined below.
Un tel dispositif comprend :
- un premier réactif comprenant un marqueur, visible et/ou mesurable, ce premier réactif étant disposé à l'état libre, dans une zone amont du premier moyen de diffusion capillaire ;
- et un second réactif fixé, c'est-à-dire immobilisé, dans la zone aval du premier moyen de diffusion capillaire, pour la capture directe ou indirecte du premier réactif ;
- a first reagent comprising a marker, visible and / or measurable, said first reagent being disposed in the free state, in an upstream zone of the first capillary diffusion means;
- and a second reagent attached, i.e. immobilized, in the downstream zone of the first capillary diffusion means, for the direct or indirect capture of the first reagent;
Le fonctionnement du dispositif précédemment décrit se déduit de la description précédente.The operation of the device previously described is deduced from the previous description.
L'utilisateur retire le capuchon, puis met l'échantillon liquide, par exemple un flot d'urine, en contact direct avec la zone de collection du deuxième moyen de diffusion capillaire. L'échantillon liquide migre d'abord, dans la direction de référence, vers la zone amont du premier moyen de diffusion capillaire, dans laquelle, d'une part il entraíne le premier réactif, et d'autre part l'analyte se lie à ce dernier, pour former un conjugué. Puis, toujours par migration capillaire de l'échantillon liquide, le conjugué précité parvient par entraínement capillaire dans la zone aval, dans laquelle le second réactif capture, et donc immobilise et concentre, directement ou indirectement, le premier réactif, et partant le conjugué. Par la fenêtre du boítier, l'existence et/ou la quantité capturée du conjugué peut être lue, et/ou mesurée, directement ou indirectement, par exemple à l'oeil nu dans le cas d'un marqueur particulaire, ou par tous moyens de détection et/ou mesure appropriés.The user removes the cap, then puts the liquid sample, for example a stream of urine, in direct contact with the collection area of the second means of capillary diffusion. The liquid sample migrates first, in the reference direction, to the zone upstream of the first capillary diffusion means, in which, on the one hand, causes the first reagent, and on the other hand the analyte binds to the latter, to form a conjugate. Then, still by capillary migration of the liquid sample, the aforementioned conjugate arrives via capillary drive in the downstream zone, in which the second reagent captures, and therefore immobilizes and concentrate, directly or indirectly, the first reagent, and hence the conjugate. Through the window of housing, the existence and / or the captured quantity of the conjugate can be read, and / or measured, directly or indirectly, for example to the naked eye in the case of a particulate marker, or by any means of detection and / or appropriate measure.
Sans que l'ensemble de réactifs mis en oeuvre ou
les réactifs soient précisés, par référence à ses figures
1 à 6, le document WO-A-97 26 083 décrit un dispositif de
détermination d'un analyte dans un échantillon liquide,
comprenant :
Le fonctionnement du dispositif précédemment décrit se déduit de sa structure :
- après collection de l'échantillon liquide, l'organe mobile est amené dans la position rétractée,
- le résultat de la réaction sur le premier moyen de diffusion capillaire, est observable au travers des deux fenêtres registrées de l'organe mobile et du support de préhension respectivement.
- after collection of the liquid sample, the movable member is brought into the retracted position,
- the result of the reaction on the first capillary diffusion means is observable through the two registered windows of the movable member and the gripping support respectively.
Les deux dispositifs précédemment décrits, ont en commun, d'une part la disposition des deux moyens de diffusion capillaire, sur un seul et même élément, à savoir le support de préhension dans le premier cas, et l'organe mobile dans le second cas, et d'autre part une continuité structurelle d'écoulement capillaire, c'est à dire permanente, de l'échantillon liquide du deuxième moyen de diffusion capillaire vers le premier moyen de diffusion capillaire.The two devices previously described, have in on the one hand, the provision of the two means of capillary diffusion, on one and the same element, know the grip support in the first case, and the movable organ in the second case, and on the other hand a structural continuity of capillary flow, this is at say permanent, the liquid sample of the second means of capillary diffusion to the first means of capillary diffusion.
La présente invention a pour objet un dispositif
permettant de supprimer tout moyen supplémentaire de
protection amovible de la zone de collection de
l'échantillon liquide, tout en isolant cette dernière par
rapport à l'extérieur du dispositif, tant que ce dernier
n'est pas utilisé, c'est à dire mis en oeuvre ou armé pour
le prélèvement d'un échantillon liquide, puis la lecture
du résultat concernant l'analyte.
Par rapport au document WO 97/26083, un dispositif selon
la présente invention se distingue en ce que la zone de
transfert du deuxième moyen de diffusion capillaire est
agencée de manière amovible, par rapport à une zone amont
du premier moyen de diffusion capillaire, en sorte que,
dans la position saillante de l'organe de captation,
ladite zone de transfert n'est pas en continuité
d'écoulement capillaire avec ladite zone amont, et dans la
position rétractée dudit organe de captation, ladite zone
de transfert et ladite zone amont sont en continuité
d'écoulement capillaire, tandis qu'un ensemble de réactifs
prédéterminé pour la détection et/ou quantification de
l'analyte comprend au moins, d'une part un premier réactif
comprenant un marqueur, visible et/ou mesurable, déposé à
l'état libre, ou sur le premier moyen de diffusion
capillaire, en amont de ladite zone aval, ou sur le second
moyen de diffusion capillaire, et d'autre part un second
réactif fixé dans la zone aval du premier moyen de
diffusion capillaire, pour la capture directe ou indirecte
du premier réactif. The present invention relates to a device for removing any additional means of removable protection of the collection area of the liquid sample, while isolating the latter from the outside of the device, as the latter is not used, ie used or armed for taking a liquid sample, and then reading the result concerning the analyte.
Compared to WO 97/26083, a device according to the present invention is distinguished in that the transfer zone of the second capillary diffusion means is removably arranged with respect to an upstream zone of the first capillary diffusion means, so that, in the projecting position of the capturing member, said transfer zone is not in continuity of capillary flow with said upstream zone, and in the retracted position of said capturing member, said transfer zone and said zone upstream are in continuity of capillary flow, while a set of reagents predetermined for the detection and / or quantification of the analyte comprises at least, on the one hand a first reagent comprising a marker, visible and / or measurable, deposited in the free state, or on the first capillary diffusion means, upstream of said downstream zone, or on the second capillary diffusion means, and secondly a second reagent fixed in the zone e downstream of the first capillary diffusion means, for the direct or indirect capture of the first reagent.
Par conséquent, par rapport aux documents EP-A-0291 194 et WO-A-97 26083, le dispositif selon l'invention se distingue par la dissociation des deux moyens de diffusion capillaire, et par la possibilité d'isoler temporairement ces deux moyens vis à vis de l'écoulement capillaire de l'échantillon liquide.Therefore, compared to EP-A-0291 194 and WO-A-97 26083, the device according to the invention is distinguished by the dissociation of the two means of capillary diffusion, and by the possibility of isolating temporarily these two means with respect to the flow capillary of the liquid sample.
Et de plus, par rapport au document WO-A-97 26083, le dispositif selon l'invention se distingue, outre l'ensemble de réactifs prédéterminés choisis pour la détection et/ou quantification de l'analyte, par le fait que le premier moyen de diffusion capillaire demeure du côté du support de préhension, et qu'en conséquence l'organe de captation est affecté pour l'essentiel au prélèvement de l'échantillon liquide.And moreover, compared to the document WO-A-97 26083, the device according to the invention is distinguished, besides the set of predetermined reagents chosen for the detection and / or quantification of the analyte, by the fact that the first means of capillary diffusion remains side of the gripping support, and as a result the capture organ is essentially assigned to the sampling of the liquid sample.
L'invention apporte les avantages suivants.The invention brings the following advantages.
La possibilité d'isoler, vis à vis de l'écoulement liquide les deux moyens de diffusion capillaire, permet de séparer et séquencer le prélèvement proprement dit, et la ou les réactions requises pour la détection et/ou quantification de l'analyte, à savoir d'effectuer ledit prélèvement avant la ou les réactions.The possibility of isolating, with respect to the flow liquid both capillary diffusion means, allows to separate and sequence the actual sample, and the or the reactions required for detection and / or quantification of the analyte, namely to perform said sampling before the reaction (s).
Ceci est important pour éviter le démarrage de la ou des réactions requises avant d'avoir permis un prélèvement d'une quantité maximum ou optimum de l'échantillon liquide à analyser.This is important to avoid starting the or required reactions before allowing a collection of a maximum or optimum amount of the liquid sample to be analyzed.
Le déplacement du deuxième moyen de diffusion capillaire, à l'écart et à distance du premier moyen de diffusion capillaire, permet pour une longueur ou un encombrement donné du dispositif, de disposer d'une plus grande longueur de collection de l'échantillon liquide, dans la position saillante ou en saillie dudit dispositif.The displacement of the second diffusion means capillary, away from and away from the first means of capillary diffusion, allows for a length or a given size of the device, to have a more large collection length of the liquid sample, in the projecting or protruding position of said device.
Un dispositif selon l'invention peut être utilisé avec tout ensemble de réactifs prédéterminés, en fonction de l'analyte recherché dans l'échantillon liquide, d'une part, et du protocole opératoire retenu pour la détermination d'autre part.A device according to the invention can be used with any set of predetermined reagents, depending of the desired analyte in the liquid sample, of a and the operating protocol adopted for the determination on the other hand.
Par réactif, on entend toute entité, chimique, biochimique, ou biologique susceptible de se lier avec l'analyte et/ou un autre réactif.Reagent means any entity, chemical, biochemical, or biological likely to bind with the analyte and / or another reagent.
Par "lier", ou "liaison", on entend toute liaison forte, par exemple covalente, ou faible, par exemple du type antigène/anticorps ou avidine/streptavidine.By "bind", or "link", is meant any link strong, for example covalent, or weak, for example type antigen / antibody or avidin / streptavidin.
Préférentiellement, mais de manière non exclusive, les réactifs considérés selon l'invention sont des entités biologiques, du type ligand ou anti-ligand, et ceci par rapport à l'analyte ou un autre réactif, de type biologique. Dans cette catégorie, sont rangés les réactifs tels que anticorps, antigènes, haptènes, avidine/streptavidine, mais aussi les peptides, protéines, et polynucléotides.Preferentially, but not exclusively, the reagents considered according to the invention are entities ligand or anti-ligand type, and this by relative to the analyte or other reagent, of type organic. In this category are stored the reagents such as antibodies, antigens, haptens, avidin / streptavidin, but also peptides, proteins, and polynucleotides.
A titre d'exemple, les premier et second réactifs sont respectivement deux anticorps monoclonaux spécifiques, identiques ou différents, dirigés contre l'analyte. By way of example, the first and second reagents are respectively two monoclonal antibodies specific, identical or different, directed against the analyte.
Par "marqueur", on entend toute entité physique, chimique, biochimique, ou biologique, permettant directement ou indirectement la détermination du premier réactif, en particulier lorsqu'il est lié, directement ou indirectement, à l'analyte. Un tel marqueur, connu en soi, peut être par exemple une enzyme, ou encore des particules métalliques, par exemple des particules d'or, obtenues par exemple à partir d'or colloïdal."Marker" means any physical entity, chemical, biochemical, or biological, allowing directly or indirectly the determination of the first reagent, particularly when bound, directly or indirectly indirectly, to the analyte. Such a marker, known per se, can be for example an enzyme, or particles metal, for example gold particles, obtained by example from colloidal gold.
Selon l'invention, le premier réactif est déposé sur le second moyen de diffusion capillaire, en particulier en aval de la zone de collection de l'organe de captation, ou encore le premier réactif est déposé sur le premier moyen de diffusion capillaire, en particulier en aval de la zone amont dudit premier moyen, mais en amont de la zone aval accessible à une observation externe.According to the invention, the first reagent is deposited on the second means of capillary diffusion, in particular downstream of the organ collection area of capture, or the first reagent is deposited on the first means of capillary diffusion, in particular downstream of the upstream zone of the said first means, but upstream of the downstream zone accessible to an observation external.
De manière connue en soi, l'ensemble des réactifs prédéterminés en fonction de l'analyte et du protocole de détermination, peut être mis en oeuvre selon différents formats :
- selon un format sandwich, les premier et second réactifs sont alors prédéterminés pour se lier respectivement et spécifiquement avec l'analyte, par exemple sur deux sites épitopiques, identiques ou différents de l'analyte, lorsqu'il consiste en une molécule biologique ;
- selon un format compétition, le premier réactif ou le second réactif est prédéterminé à l'identique ou de manière similaire à l'analyte, pour se lier avec l'autre réactif, en compétition avec l'analyte.
- in a sandwich format, the first and second reagents are then predetermined to bind respectively and specifically with the analyte, for example on two epitopic sites, identical or different from the analyte, when it consists of a biological molecule;
- in a competition format, the first reagent or the second reagent is predetermined identically or in a manner similar to the analyte, to bind with the other reagent, in competition with the analyte.
Et encore, dans le cas d'un analyte constitué par une entité biologique comprenant deux ligands, susceptibles de se lier respectivement avec le premier réactif et un troisième réactif, ce dernier est déposé à l'état libre, sur un support poreux, en l'occurrence le second moyen de diffusion capillaire ou le premier moyen de diffusion capillaire, à un endroit fonctionnellement en amont de la zone aval du premier moyen de diffusion. Et le deuxième réactif est prédéterminé pour la capture du troisième réactif.And again, in the case of an analyte constituted by a biological entity comprising two ligands, likely to link with the first reagent and a third reagent, the latter is deposited at the free state, on a porous support, in this case the second means of capillary diffusion or the first means capillary scattering at a functionally upstream of the downstream zone of the first diffusion means. And the second reagent is predetermined for capturing the third reagent.
Pour contrôler que la ou les réactions nécessaires à la détermination de l'analyte ont bien eu lieu, un autre réactif prédéterminé pour se lier directement ou indirectement avec le premier réactif, est fixé dans une zone adjacente mais en aval de la zone aval du premier moyen de diffusion, cette zone adjacente étant également accessible à une observation externe.To control that the necessary reaction (s) the determination of the analyte took place, another predetermined reagent for binding directly or indirectly with the first reagent, is fixed in a adjacent area but downstream of the downstream zone of the first means of diffusion, this adjacent zone being also accessible to an external observation.
A titre d'exemple, le premier réactif comprend un marqueur particulaire, par exemple des particules d'or, visibles et/ou mesurables directement, lorsqu'il est concentré dans la zone aval du premier moyen de diffusion.By way of example, the first reagent comprises a particulate marker, for example gold particles, visible and / or directly measurable, when concentrated in the downstream zone of the first diffusion means.
La présente invention est maintenant décrite par référence au dessin annexé, dans lequel :
- la figure 1 représente en perspective, avec arrachement partiel, dans la position saillante de l'organe de captation, un dispositif selon un premier mode d'exécution de l'invention ;
- la figure 2 représente le dispositif représenté à la figure 1, en coupe longitudinale et verticale, dans la position rétractée de l'organe de captation ;
- la figure 3 représente une vue en perspective, dans la position saillante de l'organe de captation, un dispositif selon un deuxième mode d'exécution de l'invention ;
- la figure 4 représente une vue éclatée en perspective du dispositif représenté à la figure 3, dans la position rétractée de l'organe de captation ;
- la figure 5 représente une vue en coupe longitudinale et horizontale du dispositif représenté à la figure 4, dans la position rétractée de l'organe de captation ;
- la figure 6 représente une vue en coupe
transversale au niveau de l'organe 42b de maintien en
position du bâtonnet 41, du dispositif représenté aux
figures 4
et 5 ; - la figure 7 représente une vue éclatée du
premier moyen de diffusion capillaire, identique pour les
deux modes d'exécution de l'invention, et mis en oeuvre
dans la même position, comme montré par les figures 1
et 2 en particulier.
- Figure 1 shows in perspective, partially broken away, in the projecting position of the capture member, a device according to a first embodiment of the invention;
- FIG. 2 represents the device represented in FIG. 1, in longitudinal and vertical section, in the retracted position of the capturing member;
- FIG. 3 represents a perspective view, in the projecting position of the capture member, of a device according to a second embodiment of the invention;
- FIG. 4 represents an exploded perspective view of the device represented in FIG. 3, in the retracted position of the capturing member;
- Figure 5 shows a longitudinal and horizontal sectional view of the device shown in Figure 4, in the retracted position of the capture member;
- Figure 6 shows a cross-sectional view at the member 42b for holding the
rod 41 in position, the device shown in Figures 4 and 5; - FIG. 7 represents an exploded view of the first capillary diffusion means, identical for the two embodiments of the invention, and implemented in the same position, as shown by FIGS. 1 and 2 in particular.
Conformément aux figures 1 et 2, un dispositif selon l'invention comprend :
- un support de préhension 1 ayant la forme d'un
boítier, comprenant, à une extrémité distale une
ouverture 1c pour le passage de l'organe de captation 4
décrit ci-après vers la position saillante, et à l'opposé
de cette extrémité une fenêtre 1d registrée avec au moins
une zone aval 2a du
premier moyen 2 de diffusion capillaire, décrit ci-après ; - le premier des deux moyens de diffusion
capillaire, ayant la forme d'une bandelette multi-couche,
solidaire du support de préhension 1, et comprenant la
zone aval 2a accessible à une observation externe ; ce premier moyen est plus particulièrement représenté en vue éclatée à la figure 2, et sera décrit ci-après en détail ; - un ensemble de réactifs prédéterminés pour la
détection et/ou quantification de l'analyte, comprenant au
moins :
- un premier réactif 31, comprenant un marqueur
visible et/ou mesurable, ce premier réactif étant disposé
à l'état libre sur le premier moyen de
diffusion 2, en particulier en aval de la zone amont 2b, dont il sera question ci-après ; - et un
second réactif 32 fixé dans lazone aval 2a du premier moyen dediffusion 2, pour la capture directe ou indirecte du premier réactif ; un autre réactif 33, prédéterminé pour se lier avec le premier réactif 31, fixé dans unezone 2c, adjacente, mais en aval de lazone aval 2a précitée dupremier moyen 2 de diffusion, cette zone adjacente étant également accessible à une observation externe, par exemple avec la même fenêtre 1d du boítier 1 ;
- un premier réactif 31, comprenant un marqueur
visible et/ou mesurable, ce premier réactif étant disposé
à l'état libre sur le premier moyen de
- un organe de captation 4 de l'échantillon
liquide, monté sur le support 1 de manière amovible, ou
inversement ;
cet organe 4 comporte un deuxième moyen 41 de diffusion capillaire, dans la même direction et le même sens 60 que ceux déterminés par le premier moyen 2 de diffusion capillaire ; ce deuxième moyen 41 s'étend de la zone de collection 41a de l'échantillon, à une zone de transfert 41b de ce dernier ; cet organe de captation 4 est mobile et déplaçable en translation, par rapport au support de préhension 1, entre deux positions extrêmes, à savoir l'une saillante (cf. figure 1) par rapport audit support de préhension, dans laquelle la zone de collection 41a est susceptible d'être mise en contact avec l'échantillon liquide, en dehors du support de préhension, et dans laquelle la zone de transfert (41b) n'est pas en continuité d'écoulement capillaire avec, et donc isolée par rapport à la zone amont (2b) du premier moyen (2) de diffusion capillaire, et l'autre rétractée (cf. figure 2), dans laquelle la zone de collection 41a est comprise dans ledit support de préhension, et dans laquelle la zone de transfert (41b) du deuxième moyen (41) de diffusion capillaire est, de manière amovible, c'est à dire temporaire, en continuité d'écoulement capillaire avec la zone amont (2b) du premier moyen (2) de diffusion capillaire ; ce qui explique que l'organe de captation 4 et le support de préhension 1 sont allongés selon la direction de translation.
- a gripping support 1 having the shape of a housing, comprising, at a distal end, an
opening 1c for the passage of the capturingmember 4 described hereinafter towards the projecting position, and opposite this end awindow 1d registered with at least onedownstream zone 2a of the first capillary diffusion means 2, described hereinafter; - the first of the two capillary diffusion means, in the form of a multi-layer strip, secured to the gripping support 1, and comprising the
downstream zone 2a accessible to an external observation; this first means is more particularly shown in exploded view in FIG. 2, and will be described hereinafter in detail; - a set of predetermined reagents for the detection and / or quantification of the analyte, comprising at least:
- a first reagent 31, comprising a visible and / or measurable marker, this first reagent being placed in the free state on the first diffusion means 2, in particular downstream of the upstream zone 2b, which will be discussed below;
- and a
second reagent 32 fixed in thedownstream zone 2a of the first diffusion means 2, for the direct or indirect capture of the first reagent; - another
reagent 33, predetermined to bind with the first reagent 31, fixed in anarea 2c, adjacent but downstream of the aforementioneddownstream zone 2a of the first diffusion means 2, this adjacent zone being also accessible to an external observation, for example with thesame window 1d of the housing 1;
- a capture member 4 of the liquid sample, mounted on the support 1 removably, or vice versa; this member 4 comprises a second means 41 of capillary diffusion, in the same direction and the same direction 60 as those determined by the first means 2 of capillary diffusion; this second means 41 extends from the collection zone 41a of the sample, to a transfer zone 41b of the latter; this capturing member 4 is movable and displaceable in translation, with respect to the gripping support 1, between two extreme positions, namely one protruding (see FIG. 1) with respect to said gripping support, in which the collection zone 41a is capable of being brought into contact with the liquid sample, outside the gripping support, and in which the transfer zone (41b) is not in continuity of capillary flow with, and therefore isolated from the upstream zone (2b) of the first capillary diffusion means (2) and the other retracted region (see FIG. 2), in which the collection zone 41a is included in the said gripping support, and in which the transfer zone (41b) of the second capillary diffusion means (41) is removably, ie temporarily, in continuity of capillary flow with the upstream zone (2b) of the first capillary diffusion means (2); this explains that the capturing member 4 and the gripping support 1 are elongate in the direction of translation.
En correspondance avec la structure générale décrite précédemment :
- la zone amont 2b du
premier moyen 2 de diffusion capillaire est agencée pour venir, de manière amovible ou temporaire, en continuité d'écoulement capillaire avec la zone de transfert 41b dusecond moyen 41 de diffusion capillaire, dans la position rétractée de l'organe de captation 4, et pour être isolée vis à vis du même écoulement capillaire, par rapport à la même zone de transfert 41b, dans la position saillante de l'organe de captation 4. - et le premier réactif 31 est déposé à l'état
libre sur le premier moyen de
diffusion 2, comme décrit précédemment, dans unezone 2a en aval de la zone amont 2b ; mais bien entendu, le premier réactif peut être déposé directement dans la zone amont 2b dupremier moyen 2 de diffusion capillaire, ou encore directement sur le deuxième moyen 41 de diffusion capillaire.
- the upstream zone 2b of the first capillary diffusion means 2 is arranged to come, removably or temporarily, in capillary flow continuity with the
transfer zone 41b of the second capillary diffusion means 41, in the retracted position of theorgan 4, and to be isolated with respect to the same capillary flow, with respect to thesame transfer zone 41b, in the protruding position of thecapture member 4. - and the first reagent 31 is deposited in the free state on the first diffusion means 2, as previously described, in an
area 2a downstream of the upstream zone 2b; but of course, the first reagent can be deposited directly in the upstream zone 2b of the first capillary diffusion means 2, or directly on the second capillary diffusion means 41.
Pour actionner le déplacement de l'organe de
captation 4, comme montré à la figure 2, le support de
préhension 1 comporte une glissière longitudinale 5, dont
la forme est adaptée à la trajectoire de déplacement dudit
organe 4, et ce dernier comporte un organe 6 de commande
manuelle traversant cette glissière. La course de l'organe
6 dans la glissière 5 détermine le deux positions extrêmes
de l'organe de captation 4, et comme montré à la figure 2,
a une longueur supérieure à la longueur de recouvrement de
la zone de transfert 41b du deuxième moyen 41 de diffusion
capillaire, et de la zone amont (2b) du premier moyen de
diffusion capillaire, dans la position rétractée du
dispositif.To actuate the displacement of the
Comme montré plus particulièrement par la
figure 7, le premier moyen 2 de diffusion capillaire est
obtenu par assemblage de différentes sections ou morceaux,
eux-mêmes fixés sur une bande 28 en matière plastique
transparente, et en continuité permanente d'écoulement
capillaire une fois assemblés les uns aux autres. As shown more particularly by the
FIG. 7, the
Conformément à la figure 7, et dans le sens et la direction 60 de l'écoulement capillaire, en plus de la bande 28 transparente, le premier moyen de diffusion capillaire 2 comporte :
une première section 21 de porosité relativement importante, par exemple en cellulose, avec une taille de pores compriseentre 2 µm et 50 µm, agencée pour venir en continuité d'écoulement capillaire avec la zone de transfert 41b dusecond moyen 41 de diffusion capillaire ; c'est cette section qui constitue la zone amont 2b dupremier moyen 2 de diffusion ;une section 22 constituée par exemple en fibre de verre, ayant une taille de pores compriseentre 2 µm et 500 µm, sur laquelle est déposé à l'état libre le premier réactif 31 ;une section 24 de porosité relativement faible, par exemple constituée en nitrocellulose, avec une porosité comprise entre 1 µm et 30 µm, comportant, et lazone aval 2a dans laquelle est fixé lesecond réactif 32, et la zone adjacente dans laquelle est fixé l'autre réactif 33, ces deux zones étant accessibles à une observation externe par la fenêtre registrée 1d du boítier 1 ;une section 27, constituée par exemple en cellulose, ayant une porosité comprise entre 2 µm et 50 µm, pour le recueil par absorption de l'ensemble des liquides ayant circulé sur lepremier moyen 2 de diffusion capillaire, au-delà des zones aval 2a ; cette section de recueil est donc solidaire du support préhension 1, et disposée en aval et en continuité d'écoulement capillaire avec lazone aval 2a du premier moyen de diffusion capillaire 1.
- a
first section 21 of relatively large porosity, for example cellulose, with a pore size of between 2 microns and 50 microns, arranged to come into capillary flow continuity with thetransfer zone 41b of the second capillary diffusion means 41; it is this section which constitutes the upstream zone 2b of the first diffusion means 2; - a
section 22 constituted for example by fiberglass, having a pore size of between 2 μm and 500 μm, on which the first reagent 31 is deposited in the free state; - a
section 24 of relatively low porosity, for example consisting of nitrocellulose, with a porosity of between 1 .mu.m and 30 .mu.m, comprising, and thedownstream zone 2a in which thesecond reagent 32 is fixed, and the adjacent zone in which is fixedother reagent 33, these two zones being accessible to external observation by the registeredwindow 1d of the housing 1; - a
section 27, constituted for example by cellulose, having a porosity of between 2 μm and 50 μm, for the collection by absorption of all the liquids having circulated on the first capillary diffusion means 2, beyond thedownstream zones 2a ; this collection section is thus secured to the gripping support 1, and disposed downstream and in continuity of capillary flow with thedownstream zone 2a of the first capillary diffusion means 1.
Le dispositif conforme aux figures 3 à 5 a la même structure générale que celle définie précédemment. Les mêmes références numériques identifient des pièces ou composants ayant la même fonction que celle décrite par référence aux figures 1 et 2. Seules les différences suivantes seront décrites ci-après.The device according to Figures 3 to 5 has the same general structure as defined above. The same numerical references identify parts or components having the same function as that described by reference to Figures 1 and 2. Only the differences following will be described below.
L'organe de captation 4 comprend un chariot 42 de
support du second moyen 41 de diffusion capillaire,
compris dans le boítier 1 ou support de préhension. Ce
dernier et le chariot 42 comportent des moyens de guidage
en déplacement dudit chariot, plus particulièrement
visibles sur la figure 6, consistant en deux glissières 45
et 46 appartenant au boítier 1, l'une supérieure et
l'autre inférieure, et alignées, et en deux nervures
correspondantes 43 et 44 appartenant au chariot 42,
coulissant dans les glissières 45 et 46 respectivement.The
Le second moyen de diffusion 41 a la forme d'un
bâtonnet relativement rigide, et le chariot 42 comporte
une butée arrière 42a par rapport au sens de déplacement
dudit chariot, et un organe 42b de maintien en position du
bâtonnet 41, ayant la forme d'un anneau.The second diffusion means 41 is in the form of a
relatively rigid rod, and the
Le boítier 1 intègre également un moyen 47
d'actionnement du chariot 42, avec une commande manuelle
48. Plus précisément, le moyen d'actionnement 47 comprend
une bande 49 semi-rigide, conformée en épingle, dont une
branche 49a comporte sur sa face extérieure un organe 48
de préhension, et dont l'autre branche a une extrémité
liée au chariot 42. En correspondance, le boítier 1
comprend un chemin 50 de guidage et tirage de la bande,
également conformé en épingle, et d'autre part une
fenêtre 1f adaptée au passage de l'organe de
préhension 48, dont la longueur est adaptée à la course de
déplacement de l'organe de captation 4. comme le montre
bien le rapprochement des figures 4 et 5, cette course a
une longueur bien supérieure à la longueur de recouvrement
de la zone de transfert 41 b du deuxième moyen de
diffusion capillaire 41, et de la zone amont 2b du premier
moyen de diffusion capillaire 2, dans la position
rétractée du dispositif. The housing 1 also includes a
Par conséquent, en repoussant l'organe 48 de
préhension vers l'extrémité proximale du boítier 1, comme
montré à la figure 3, la bande 49 circule dans le
chemin 50 de guidage et repousse le chariot 42 vers la
position saillante de l'organe de captation 2. En sens
inverse, le chariot 42 est déplacé vers la position
rétractée de l'organe de captation 4.Therefore, by pushing
Comme le montrent également les figures 4 et 5, le
premier moyen 2 de diffusion capillaire est serré et
maintenu à l'intérieur du boítier entre des nervures le
disposées parallèlement à la direction 60 du flux
capillaire.As also shown in Figures 4 and 5, the
Le fonctionnement d'un dispositif selon l'invention se déduit de la description précédente :
- au départ, c'est-à-dire avant utilisation,
l'organe 4 de captation est dans la position rétractée (cf. Fig.2 et 4), de telle sorte que le boítier 1 est une entité fermée, à l'exception de la fenêtre 1d ; dans le cas de la figure 1,c'est un volet 61, solidaire de l'extrémité proximale de l'organe de captation 4, qui ferme l'ouverture 1c ; et dans le cas des figures 4et 5, c'est l'extrémité de la bande 49 semi-rigide, opposée au chariot 42, qui obture l'ouverture 1c (cf. figure 5) ; - par l'organe de commande 6
ou 48, l'utilisateur amène l'organe de captation 4 dans la position saillante, dans laquelle un flux ou échantillon liquide contenant l'analyte est mis en contact avec la zone de collection 41a ; - avec la même main, le même organe de captation est ramené dans la position rétractée, avec fermeture de l'ouverture 1c, comme décrit précédemment
- c'est uniquement dans cette dernière position,
sans autre intervention de l'utilisateur, que
l'échantillon liquide migre successivement du deuxième
moyen de
diffusion capillaire 41, vers le premier moyen dediffusion capillaire 42, et sur ce dernier de l'amont vers l'aval ; les réactions générées par les réactifs précédemment décrits s'effectuent ; le résultat est accessible à une observation externe par la fenêtre 1d, par exemple à l'oeil nu ; - puis le dispositif de détermination, à usage
unique, peut être jeté, dans la position rétractée des
Figures 2
et 4.
- initially, that is to say before use, the
capture member 4 is in the retracted position (see Fig.2 and 4), so that the housing 1 is a closed entity, with the exception fromwindow 1d; in the case of Figure 1, it is aflap 61 integral with the proximal end of thesensor member 4, which closes theopening 1c; and in the case of Figures 4 and 5, it is the end of theband 49 semi-rigid, opposite thecarriage 42, which closes theopening 1c (see Figure 5); - by the
6 or 48, the user brings thecontrol member sensor member 4 into the projecting position, in which a flow or liquid sample containing the analyte is brought into contact with the collection zone 41a; - with the same hand, the same capture member is returned to the retracted position, with closure of the
opening 1c, as previously described - it is only in this latter position, without further intervention by the user, that the liquid sample migrates successively from the second capillary diffusion means 41, to the first capillary diffusion means 42, and on the latter from the upstream to the the downstream; the reactions generated by the reagents described above are carried out; the result is accessible to an external observation through the
window 1d, for example with the naked eye; - then the disposable determination device can be discarded in the retracted position of Figures 2 and 4.
Conformément à la figure 5, par rapport au sens de
l'observation par la fenêtre 1d, on observera que la zone
de transfert 41b du deuxième moyen 41 de diffusion
capillaire vient au-dessous de la zone amont 2b du premier
moyen 2 de diffusion capillaire, dans la position
rétractée de l'organe 4 de captation, et ce pour favoriser
l'écoulement capillaire à la jonction entre les deux
moyens 2 et 41 de diffusion capillaire, dans la position
rétractée de l'organe de captation 4.In accordance with Figure 5, in relation to the meaning of
the observation by the
Claims (11)
- Device for determination of an analyte in a liquid sample, comprising:a) a support (1) to be gripped;b) a first means (2) for capillary diffusion in a reference direction (60), secured to the support (1) to the gripped, comprising a downstream zone (2a) which is accessible to external observation;c) a predetermined reagent (32) for detecting and/or quantifying the analyte, fixed in the downstream zone (2a) of the first capillary diffusion means;d) a second capillary diffusion means (41) with, on the one hand, a zone (41a) for collecting the said sample and, on the other hand, a transfer zone (41b) opposite the said collection zone (41a);e) a component (4) for taking up the liquid sample, to which the second capillary diffusion means (41) is secured, mounted so that it can move with respect to the said support to be gripped, between two extreme positions, namely:one which protrudes from the said support to be gripped, in which the collecting zone (41a) of the second capillary diffusion means (41) can be brought into contact with the liquid sample outside of the support to be gripped,and the other which is retracted, in which the collection zone (41a) of the second capillary diffusion means (41) is contained in the support to be gripped,
- Device according to Claim 1, characterized in that the reagent (31) comprising the marker is deposited on the second diffusion means (41), in particular downstream of the collection zone (41a).
- Device according to Claim 1, characterized in that the reagent (31) comprising the marker is deposited on the first diffusion means (2), in particular downstream of the said upstream zone (2b).
- Device according to Claim 1, characterized in that the support (1) to be gripped is in the form of a kit which, at one end, comprises an opening (1c) for the take-up component (4) to pass through into the protruding position, and on the opposite side from the said end, a window (1d) registered with at least the downstream zone (2a) of the first capillary diffusion means (2).
- Device according to Claim 1, characterized in that the support (1) to be gripped includes a slideway (5) whose shape is adapted to the path along which the take-up component (4) moves, and the said take-up component includes a manual control component (6) passing through the said slideway.
- Device according to Claim 1, characterized in that the take-up component (4) can be moved and be translated relative to the support (1) to be gripped, and the said component and the said support are elongated in the translation direction.
- Device according to Claim 1, characterized in that the first capillary diffusion means (2) includes two separate sections, in permanent capillary flow continuity, namely a first section (21) of relatively high porosity, designed to come removably into capillary flow continuity with the transfer zone (41b) of the second capillary diffusion means (41), and a second section (24) of relatively low porosity, including the said downstream zone (2a).
- Device according to Claim 4, characterized in that the take-up component (4) comprises a carriage (42) for supporting the second capillary diffusion means (41), the kit and the carriage includes means (43 to 46) for guiding the said carriage as it moves, and the kit incorporates a means (47) for actuating the said carriage, with manual control (48).
- Device according to Claim 8, characterized in that the second diffusion means (41) is in the form of a stick, and the carriage includes a rear stop (42a) relative to the direction of movement, and a component (42b) for holding the said stick in position.
- Device according to Claim 8, characterized in that the actuation means (47) comprises a hairpin-shaped semirigid band (49), one branch (49a) of which has a component (48) to be gripped on its outer face, and the other branch (49b) of which has an end joined to the carriage (42), and in that the kit (1) comprises, on the one hand, a path (50) which is intended for pulling the band and is also shaped as a hairpin, and on the other hand a window (1d) which is designed for the passage of the component (48) to be gripped, and whose length is adapted to the displacement travel of the take-up component (4).
- Device according to Claim 4, characterized in that the first capillary diffusion means (2) is clamped and held inside the kit, between ribs (1c) extending parallel to the direction of the capillary flow.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808480 | 1998-06-30 | ||
FR9808480A FR2780317B1 (en) | 1998-06-30 | 1998-06-30 | DEVICE FOR DETERMINING AN ANALYTE IN A LIQUID SAMPLE |
PCT/FR1999/001380 WO2000000288A1 (en) | 1998-06-30 | 1999-06-10 | Device for determining an analyte in a liquid sample |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1091808A1 EP1091808A1 (en) | 2001-04-18 |
EP1091808B1 true EP1091808B1 (en) | 2003-07-09 |
Family
ID=9528186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99925064A Expired - Lifetime EP1091808B1 (en) | 1998-06-30 | 1999-06-10 | Device for determining an analyte in a liquid sample |
Country Status (16)
Country | Link |
---|---|
US (1) | US7459125B1 (en) |
EP (1) | EP1091808B1 (en) |
JP (1) | JP4505138B2 (en) |
CN (1) | CN1185050C (en) |
AT (1) | ATE244602T1 (en) |
AU (1) | AU4148399A (en) |
CA (1) | CA2335458A1 (en) |
DE (1) | DE69909484T2 (en) |
ES (1) | ES2204132T3 (en) |
FR (1) | FR2780317B1 (en) |
HU (1) | HUP0102735A3 (en) |
IL (1) | IL140165A (en) |
PL (1) | PL194051B1 (en) |
RS (1) | RS49670B (en) |
RU (1) | RU2205693C2 (en) |
WO (1) | WO2000000288A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2873208A1 (en) * | 2004-07-13 | 2006-01-20 | Vedalab Sa | DEVICE WITH A SAMPLING MEMBER FOR DETECTION OF AN ANALYTE IN A LIQUID SAMPLE |
US8709826B2 (en) | 2005-08-23 | 2014-04-29 | Vedalab | Analyte assaying by means of immunochromatography with lateral migration |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6773677B2 (en) * | 2002-01-09 | 2004-08-10 | Caliper Life Sciences, Inc. | Slide cassette for fluidic injection |
ES2525318T3 (en) * | 2002-10-11 | 2014-12-22 | Zbx Corporation | Diagnostic devices |
EP1718973B1 (en) * | 2004-02-09 | 2009-09-09 | Rapid Pathogen Screening Inc. | Method for the rapid diagnosis of targets in human body fluids |
CN101498717B (en) * | 2005-04-30 | 2013-08-28 | 美艾利尔瑞士公司 | Sample collecting device used for collecting solid or semi-solid sample |
GB0811132D0 (en) * | 2008-06-18 | 2008-07-23 | Secr Defence | Detection device |
WO2010009301A1 (en) * | 2008-07-17 | 2010-01-21 | The Procter & Gamble Company | Method of using a flow cell apparatus for visualizing additive deposition on a substrate |
AU2010330825B2 (en) * | 2009-12-18 | 2014-03-06 | Abbott Point Of Care, Inc. | Biologic fluid analysis cartridge |
BG110608A (en) * | 2010-03-01 | 2011-09-30 | Zentax Limited | Pregnancy tester |
US9744014B2 (en) * | 2010-10-15 | 2017-08-29 | Nestec S.A. | Oral engagement assemblies |
FR2997194B1 (en) | 2012-10-24 | 2014-11-28 | Milovan Stankov | DEVICE FOR DETERMINING AT LEAST ONE ANALYTE LIKELY TO BE CONTAINED IN A LIQUID SAMPLE |
US9592507B2 (en) * | 2012-06-22 | 2017-03-14 | Abbott Point Of Care Inc. | Integrated cartridge housings for sample analysis |
MX2017013898A (en) * | 2015-04-30 | 2018-08-15 | Wellmetris Llc | Sample collection device and method for urine and other fluids. |
WO2018079916A1 (en) * | 2016-10-28 | 2018-05-03 | 주식회사 바이탈스미스 | Image processing and analyzing system for ovulation detection and method for controlling same |
CN109890297A (en) * | 2016-10-28 | 2019-06-14 | 株式会社马尼金 | For determining the image processing and analysis system and its control method of ovulation day |
EP3619532B1 (en) | 2017-05-02 | 2022-07-13 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Plasma/serum separator device and methods using the same |
GB201816559D0 (en) * | 2018-10-10 | 2018-11-28 | Spd Swiss Prec Diagnostics Gmbh | Compact testing device |
EP4188600B1 (en) | 2020-07-29 | 2024-06-05 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Device for separation and/or preservation of a biofluid at a point-of-care, kit and method for identifying a disease |
CA3167468A1 (en) * | 2022-03-15 | 2023-09-15 | Zhejiang Orient Gene Biotech Co., Ltd. | Device for detecting an analyte in a liquid sample |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4774192A (en) * | 1987-01-28 | 1988-09-27 | Technimed Corporation | A dry reagent delivery system with membrane having porosity gradient |
DE291194T1 (en) | 1987-04-27 | 1992-03-19 | Unilever N.V., Rotterdam | IMMUNOASSAYS AND DEVICES FOR THIS. |
US4981786A (en) * | 1987-09-04 | 1991-01-01 | Syntex (U.S.A.) Inc. | Multiple port assay device |
ATE154979T1 (en) * | 1993-03-17 | 1997-07-15 | Akzo Nobel Nv | DEVICE FOR DETERMINING A SPECIFIC REACTING SUBSTANCE |
JP2665647B2 (en) * | 1993-07-08 | 1997-10-22 | 三共株式会社 | Portable diagnostic tool |
WO1995008761A1 (en) * | 1993-09-20 | 1995-03-30 | Polyfiltronics, Inc. | Analytical test formats and methods of conducting analytical tests |
IT1281738B1 (en) * | 1996-01-17 | 1998-02-27 | Boehringer Mannheim Italia | DEVICE FOR PERFORMING RAPID DIAGNOSTIC TESTS ON LIQUID SAMPLES |
US5980828A (en) * | 1996-05-28 | 1999-11-09 | Universal Healthwatch, Inc. | Combined sampling-assay device and holder |
AUPO071396A0 (en) * | 1996-06-28 | 1996-07-25 | Chandler, Howard Milne | Chromatographic assay or test device |
JP3753282B2 (en) * | 1996-07-29 | 2006-03-08 | 久光製薬株式会社 | Inspection device |
US6372514B1 (en) * | 1998-09-18 | 2002-04-16 | Syntron Bioresearch, Inc. | Even fluid front for liquid sample on test strip device |
US6140136A (en) * | 1998-09-18 | 2000-10-31 | Syntron Bioresearch, Inc. | Analytical test device and method of use |
US6150178A (en) * | 1999-03-24 | 2000-11-21 | Avitar, Inc. | Diagnostic testing device |
US6365417B1 (en) * | 2000-02-09 | 2002-04-02 | A-Fem Medical Corporation | Collection device for lateral flow chromatography |
-
1998
- 1998-06-30 FR FR9808480A patent/FR2780317B1/en not_active Expired - Fee Related
-
1999
- 1999-06-10 JP JP2000556871A patent/JP4505138B2/en not_active Expired - Fee Related
- 1999-06-10 AT AT99925064T patent/ATE244602T1/en not_active IP Right Cessation
- 1999-06-10 EP EP99925064A patent/EP1091808B1/en not_active Expired - Lifetime
- 1999-06-10 DE DE69909484T patent/DE69909484T2/en not_active Expired - Lifetime
- 1999-06-10 ES ES99925064T patent/ES2204132T3/en not_active Expired - Lifetime
- 1999-06-10 CA CA002335458A patent/CA2335458A1/en not_active Abandoned
- 1999-06-10 IL IL14016599A patent/IL140165A/en not_active IP Right Cessation
- 1999-06-10 US US09/720,862 patent/US7459125B1/en not_active Expired - Fee Related
- 1999-06-10 WO PCT/FR1999/001380 patent/WO2000000288A1/en active IP Right Grant
- 1999-06-10 HU HU0102735A patent/HUP0102735A3/en unknown
- 1999-06-10 CN CNB998081264A patent/CN1185050C/en not_active Expired - Fee Related
- 1999-06-10 PL PL99345160A patent/PL194051B1/en unknown
- 1999-06-10 RS YUP-833/00A patent/RS49670B/en unknown
- 1999-06-10 AU AU41483/99A patent/AU4148399A/en not_active Abandoned
- 1999-06-10 RU RU2001102607/04A patent/RU2205693C2/en not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2873208A1 (en) * | 2004-07-13 | 2006-01-20 | Vedalab Sa | DEVICE WITH A SAMPLING MEMBER FOR DETECTION OF AN ANALYTE IN A LIQUID SAMPLE |
WO2006016051A2 (en) * | 2004-07-13 | 2006-02-16 | Vedalab | Device with removal member for detecting an analyte in a liquid sample |
WO2006016051A3 (en) * | 2004-07-13 | 2006-08-10 | Vedalab | Device with removal member for detecting an analyte in a liquid sample |
US8709826B2 (en) | 2005-08-23 | 2014-04-29 | Vedalab | Analyte assaying by means of immunochromatography with lateral migration |
Also Published As
Publication number | Publication date |
---|---|
IL140165A0 (en) | 2002-02-10 |
IL140165A (en) | 2004-05-12 |
RU2205693C2 (en) | 2003-06-10 |
ES2204132T3 (en) | 2004-04-16 |
CN1185050C (en) | 2005-01-19 |
FR2780317A1 (en) | 1999-12-31 |
HUP0102735A2 (en) | 2001-11-28 |
YU83300A (en) | 2003-04-30 |
RS49670B (en) | 2007-09-21 |
DE69909484D1 (en) | 2003-08-14 |
DE69909484T2 (en) | 2004-04-15 |
US7459125B1 (en) | 2008-12-02 |
JP2002519650A (en) | 2002-07-02 |
EP1091808A1 (en) | 2001-04-18 |
WO2000000288A1 (en) | 2000-01-06 |
ATE244602T1 (en) | 2003-07-15 |
AU4148399A (en) | 2000-01-17 |
JP4505138B2 (en) | 2010-07-21 |
PL194051B1 (en) | 2007-04-30 |
CA2335458A1 (en) | 2000-01-06 |
CN1308562A (en) | 2001-08-15 |
FR2780317B1 (en) | 2000-08-11 |
HUP0102735A3 (en) | 2005-11-28 |
PL345160A1 (en) | 2001-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1091808B1 (en) | Device for determining an analyte in a liquid sample | |
JP4314232B2 (en) | Biochemical assay | |
JP4891317B2 (en) | Membrane array and analytical equipment | |
US6372516B1 (en) | Lateral flow test device | |
US20040019301A1 (en) | Integrated confirmation sample in a body fluid test device and method of using | |
EP1917529B1 (en) | Analyte assaying by means of immunochromatography with lateral migration | |
US6770447B2 (en) | Optical assay device and method | |
JP3727952B2 (en) | Automated immunoassay cassette | |
US20100068826A1 (en) | Hybrid phase lateral flow assay | |
JP2004509319A (en) | Assay device and method of using the same | |
WO2006016051A2 (en) | Device with removal member for detecting an analyte in a liquid sample | |
WO1998048280A1 (en) | Device for detection of a substance in a liquid sample | |
JP3791640B2 (en) | Inspection device | |
US20080311680A1 (en) | Method for detecting high antigen concentration and device therefor | |
WO2022029083A1 (en) | System for rapid analysis of a biological sample, intended for detecting the presence of at least one analyte in the biological sample | |
EP1870160A1 (en) | Package for body secretion collecting tool | |
EP4281772A1 (en) | System for rapid analysis of a capillary blood sample from a subject, for detecting the presence of at least one analyte in said capillary blood sample | |
WO2023222728A1 (en) | System for rapid analysis of a biological sample intended for detecting the presence of at least one analyte in the biological sample | |
MXPA00012516A (en) | Device for determining an analyte in a liquid sample | |
ITMI971406A1 (en) | IMMUNOCROMATOGRAPHIC DEVICE FOR FIXING THE ANALYT | |
WO2022207890A1 (en) | Device for rapid analysis of a biological sample, for example a salivary biological sample | |
FR2875910A1 (en) | Immuno-chromatographic diagnostic test strip for detection of specific analyte in liquid, includes second bonding reagent combined with marker which is visible or can be measured | |
FR2883375A1 (en) | Body secretion e.g. saliva, analyzing package for detecting consumption of e.g. marihuana, has swab including padded end introduced in input end of channel and sliding along length of channel to make contact with strip of cassette | |
FR3111430A1 (en) | System for the rapid analysis of a biological sample, intended for the detection of the presence of at least one analyte in said biological sample | |
WO2023067288A1 (en) | System for detecting a target substance in a sample |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010129 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20010129;LT PAYMENT 20010129;LV PAYMENT 20010129;MK PAYMENT 20010129;RO PAYMENT 20010129;SI PAYMENT 20010129 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
17Q | First examination report despatched |
Effective date: 20020612 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030709 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030709 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 69909484 Country of ref document: DE Date of ref document: 20030814 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: FRENCH |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031009 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031009 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20031104 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031209 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20030709 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2204132 Country of ref document: ES Kind code of ref document: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040610 |
|
26N | No opposition filed |
Effective date: 20040414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040630 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040630 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040630 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040630 |
|
BERE | Be: lapsed |
Owner name: *VEDALAB Effective date: 20040630 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FI Payment date: 20060519 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20060523 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20070616 Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1038523 Country of ref document: HK |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070610 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070611 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20090527 Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080610 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20090518 Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20110101 |
|
EUG | Se: european patent has lapsed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100611 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20180416 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20180412 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20180412 Year of fee payment: 20 Ref country code: ES Payment date: 20180725 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69909484 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20190609 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20190609 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20200724 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20190611 |